Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Neoadjuvant AGS-003 Immunotherapy in Patients With Localized Kidney Cancer <pT2

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02170389
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:39.824465+00:00
Published At
2020-01-06T00:00:00+00:00
Record Updated At
2020-07-07
Results Posted At
2020-01-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Renal Cell Carcinoma", "Stage I Renal Cell Cancer", "Stage II Renal Cell Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-07-07"
protocolSection.identificationModule.nctId
"NCT02170389"
protocolSection.identificationModule.officialTitle
"Neoadjuvant AGS-003 Immunotherapy in Patients With Localized Kidney Cancer \u0026lt;pT2"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-01-06"

Study condition terms

  • Recurrent Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Renal Cell Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.